Universal Cells
Brad Miller is currently the Associate Director Quality Assurance at Universal Cells. Previously, Brad worked at Bio-Rad Laboratories for over a decade in various roles including Production Manager II and Quality Control Manager II. With a background in Cellular and Molecular Biology, Brad has also held positions at GSK, SNBL USA, Ostex International, and Targeted Genetics where Brad provided expertise in quality control, validation, and quality assurance.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.